Christopher Fuglesang, 10% Owner, Director at Mirati Therapeutics, Inc. (MRTX), sold 400,003 shares at $202.00 ($80.8M) on 2020-10-30, disclosed to the SEC on 2020-10-30.
Open-market sale of $80.8M MRTX by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $202.00 | 37,050 | $7.5M | 9.3% |
| 2 | $202.00 | 362,950 | $73.3M | 90.7% |
| 3 | $219.97 | 1 | $220 | 0.0% |
| 4 | $219.97 | 2 | $440 | 0.0% |
| Total | $202.00 avg | 400,003 | $80.8M | 100% |
| Filing → |